Shitanshu Uppal

Publications Update # 144

A Ted Talk on building a career, question of the week, PARP inhibitors update on long-term use, and GYOEDU PARP video, Early-Stage Cervical Cancer video, and GYOEDU study summary app launched

GYOEDU Study Summary App Privacy

Publications Update # 143

Lack of menopause treatments in cancer survivors. Video tutorial on the Management of a WHO score 5 or 6 low-risk GTN and genetic referral in endometrial cancer in patients aged < 50 years.

Fulvestrant + Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer (NCT03643510)

GROINSS-V I: Sentinel Node Dissection as Sole Groin Staging in Early-Stage Vulvar Cancer

EMPOWER-Cervical 1 (GOG-3016 / ENGOT-cx9): Cemiplimab vs. Chemotherapy in Recurrent/Metastatic Cervical Cancer

PORTEC-4a: Molecular Profile-Based Adjuvant Treatment for High-Intermediate Risk Endometrial Cancer

AtTEnd: Atezolizumab plus Chemotherapy for Advanced or Recurrent Endometrial Cancer

SOLO2/ENGOT-Ov21: Maintenance Olaparib in Platinum-Sensitive Relapsed Ovarian Cancer (Final OS Analysis)

AURELIA: Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer